U

UroGen Pharma, Inc

Develops RTGel-based drug delivery for uro-oncology

Medical Science Liaison

Biology & BiotechConfirmed live in the last 24 hours
Full-timeIllinois, USANo salary listedRemote

About the Job

Requirements

  • A doctoral degree in a clinical specialty (M.D., Pharm.D., or PhD.) is required.
  • At least 5 years of experience following the last stage of training, including at least 3 years of medical affairs or MSL experience in the pharmaceutical industry, is required.
  • Experience in urology, oncology, or a related field is required.
  • Excellent oral and written communication skills, including presentation skills, are required.
  • Demonstrated interpersonal skills are required, including the ability to understand and respond to multiple external and internal customers’ demands and manage conflict constructively.
  • Demonstrated clinical or scientific technical skills, including experience working with clinical trials, are required.
  • A solid understanding of and adherence to SOPs, rules, and regulations regarding internal and external company and customer interactions and activities is required.
  • Ability to manage a significant volume of field-based projects, prioritize, provide oversight, and exercise sound judgment is required.
  • Ability to work within the medical group and across multidisciplinary teams to accomplish responsibilities and goals is required.
  • Ability to leverage and navigate internal departments to accomplish multifaceted projects and duties is required.
  • Ability to collaborate effectively and demonstrate leadership and teamwork with peers, internal stakeholders, and external customers to build alignment and partnership around a shared vision or strategy is required.
  • Ability to work independently, take accountability, and deliver results with urgency is required.

Responsibilities

  • Establish peer-to-peer relationships and engage in scientific exchange on research and clinical trends in urology, urologic oncology, and the company’s therapeutic areas of interest throughout the product lifecycle.
  • Contribute to and represent the company’s therapeutic strategy established by Medical Affairs and Clinical Development, in alignment with brands, and work with other departments and colleagues in the field and at corporate offices.
  • Provide field-based clinical support to healthcare professionals by responding to unsolicited medical-information requests, including payer requests; identify and facilitate clinical or scientific opportunities; and deliver educational presentations.
  • Support clinical development programs by translating external insights into company programs and clinical value in study design, site selection, and company-sponsored trial field support; assist in developing an investigator-initiated trials strategy.
  • Participate in regional symposia, medical advisory boards, and other national and regional medical meetings.
  • Attend scientific conferences to gather and convey scientific information useful to thought leaders and the company, maintain current scientific expertise, and provide medical information in compliant exhibit-booth settings as needed.
  • Assist in developing and leading larger-scale projects and relevant initiatives, and contribute to team leadership and mentoring activities as directed or proactively identified.
  • Strengthen relationships between the company and the disease-area community through objective clinical education, support for research, and peer-to-peer scientific exchange; convey feedback and insights about therapeutic products, clinical trends, and research to the company.

About the Company

UroGen Pharma, Inc

Develops RTGel-based drug delivery for uro-oncology

UroGen Pharma develops RTGel-based drug-delivery therapies for urothelial and specialty cancers, commercializing products like Jelmyto and ZUSDURI and advancing a pipeline that includes UGN-102, UGN-103, UGN-104, and UGN-301. Its RTGel platform is liquid at cool temperatures and gels at body temperature, allowing chemotherapy to stay at the treatment site longer for local, sustained exposure. The company differentiates itself by delivering established chemotherapy directly to the disease site to reduce systemic exposure and by building a multi-product portfolio focused on urothelial cancers. Its goal is to improve local treatment outcomes and grow a diversified, globally commercial portfolio through ongoing clinical development and partnerships.

Company size
201-500
Company stage
IPO
Headquarters
Princeton, NJ
Founded
2004

Recently Posted Jobs

Explore more opportunities at UroGen Pharma, Inc

See more jobs